High-Dose Influenza Vaccine to Reduce Hospitalizations
The New England Journal of Medicine
|
August 30 2025
Superior protection against laboratory-confirmed influenza has been proved for high-dose inactivated influenza vaccine, as compared with the standard dose, among adults 65 years of age or older. However, data on the relative effectiveness of the high-dose vaccine against severe clinical outcomes, including hospitalizations, are limited.
